ALVO Alvotech

$5.05▼ -4.54% Healthcare Other
After hours $5.05▲ +0.00% Sep 14, 7:30 PM ET
Volume 674.2K Avg Volume (10D) 748.1K
Key Metrics & Fundamentals
Market Cap
$1.80B
P/E Ratio
33.8
Div Yield
–%
52W Range
2.94 - 9.25
% vs 50 MA
30.36%
% vs 200 MA
27.44%
RSI-14
69.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.53
Free Cash Flow
-$64.56M
Gross Rev
$105.77M
Gross Profit
$53.58M
EBITDA
-$40.14M
COGS
$52.20M
Operating Exp
$65.28M
Operating Income
-$11.71M
EBIT
-$11.71M
Pretax Income
-$66.76M
Net Income
-$66.82M
Price & Volume History
Loading chart…
Recent News
Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says
MT Newswires · Sep 10, 2026 3:57 PM
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Aug 31, 2026 7:56 PM
Update: Alvotech Shares Rise After FDA Accepts Biologics License Application for AVT80
MT Newswires · Aug 31, 2026 6:47 PM
Sector Update: Healthcare Stocks Decline Monday Afternoon
MT Newswires · Aug 31, 2026 5:37 PM
Alvotech Says FDA Accepted Biologics License Application for AVT80
MT Newswires · Aug 31, 2026 9:31 AM
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
GlobeNewswire · Aug 31, 2026 8:30 AM
Has Alvotech (NasdaqGM:ALVO) Fallen Below Fair Value After Its Deal?
Simply Wall St. · Aug 29, 2026 10:09 PM
Why Alvotech (ALVO) Is Up 11.7% After Expanding Biosimilar Deal With Lotus Pharmaceutical
Simply Wall St. · Aug 29, 2026 11:07 AM
Bank of America sees major upside in this biotech stock
TheStreet · Aug 28, 2026 6:33 PM
Alvotech to present at upcoming investor conferences in September
GlobeNewswire · Aug 27, 2026 12:00 PM
Financial Overview - Income Statement Quarterly

See ALVO's money flow as a full page

Social Sentiment
Avg +0.60 · 3 posts
DiscussionPriceTargetWhy i (Still) think $ALVO is undervalued at these levels.
r/stocks · May 12, 2026
The post’s title and focus are centered around Alvo, indicating a positive sentiment.
positive +0.60
DDTradeNewsYOLO’d half my networth into biosimilar calls
r/wallstreetbets · Feb 4, 2025
The author discusses investment in Alvotech and its performance, indicating a positive sentiment.
positive +0.60
DiscussionNewsIceland: No ETFs or ADRs, What Now?
r/investing · Oct 4, 2024
The author expresses interest in investing in ALVO as part of a diversification strategy, indicating a positive sentiment.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙